منابع مشابه
The difficulty of adequate risk stratification for patients with asymptomatic diabetes.
A 43-year-old man with type 2 diabetes mellitus was referred for cardiovascular risk assessment 2 years ago. Other risk factors for coronary artery disease included hypercholesterolemia, smoking, and a family history of coronary artery disease. The patient was asymptomatic. Physical examination was unremarkable; his body mass index was 22 kg/m and his blood pressure was 125/80 mm Hg. Hyperchole...
متن کاملRisk stratification, risk adjustment, and other risks.
“BUT our patients are sicker than yours!” is the refrain when physicians are faced with adverse comparisons of their patients’ outcomes with those of other groups, hospitals, or health systems. Meaningful and fair comparison of clinical performance requires statistical adjustment of outcomes for differences in clinical acuity of patients treated and complexity of procedures performed, among oth...
متن کاملRisk stratification in Brugada syndrome.
Kathryn A Glatter*, Nipavan Chiamvimonvat, Matti Viitasalo, Qing Wang, and Dipika Tuteja Department of Cardiology,University of California, Davis, Sacramento, CA 95817, USA (KAG, NC, DT); Department of Cardiology,Helsinki University Hospital, Helsinki, Finland (MV); and Center for Cardiovascular Genetics and Department of Molecular Cardiology Cardiology, Cleveland Clinic Foundation, Cleveland, ...
متن کاملRisk Stratification in Brugada Syndrome
Silvia G. Priori, MD, PHD,*†‡ Maurizio Gasparini, MD,§ Carlo Napolitano, MD, PHD,*‡ Paolo Della Bella, MD, Andrea Ghidini Ottonelli, MD,¶ Biagio Sassone, MD,# Umberto Giordano, MD,** Carlo Pappone, MD,†† Giosuè Mascioli, MD,‡‡ Guido Rossetti, MD,§§ Roberto De Nardis MD, Mario Colombo, MS¶¶ Pavia, Rozzano, Milano, Lido di Camaiore, Bentivoglio, Palermo, Ravenna, Bergamo, Cuneo, and Vicenza, Ital...
متن کاملAcute coronary syndromes: risk stratification.
syndromes aims to identify those patients at greatest risk of recurrent ischaemic events who might benefit prognostically from further investigation and treatment. Unfortunately, however, none of the clinical or investigative markers currently available has suYcient diagnostic power to identify all high risk patients while excluding those at negligible risk. Moreover, for patients judged to be ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Deutsches Aerzteblatt Online
سال: 2018
ISSN: 1866-0452
DOI: 10.3238/arztebl.2018.0145a